Skip to content

Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation

Reproducibility of 6 Minute Walk Tests for Oxygen Desaturation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00740220
Acronym
6MWT
Enrollment
97
Registered
2008-08-22
Start date
2006-09-30
Completion date
2009-01-31
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anoxia, Chronic Obstructive Pulmonary Disease, Hypoxemia

Keywords

hypoxemia, anoxia, oxygen, dyspnea, pulmonary disease, chronic obstructive

Brief summary

This trial will test the hypothesis that the 6 minute walk test (6MWT) is not reproducible as a measure for oxygen desaturation.

Detailed description

Over 16 million adults in the United States are afflicted with chronic obstructive pulmonary disease (COPD) and is the fourth leading cause of death.(McCrory et al. 1190-209). COPD accounts for direct health-care costs of $18 billion.(McCrory et al. 1190-209). Oxygen therapy has been shown to decrease mortality in COPD patients with severe hypoxemia at rest. Oxygen therapy now accounts for the number one expenditure for durable medical equipment. Current requirements for oxygen therapy for COPD patients include a resting or exercise paO2 or spO2 of 55 mmHg or 88% respectively. We have shown that a resting spO2 of \< 95% is predictive of those at risk of exercise induced hypoxemia in COPD patients(Knower et al. 732-36) based on continuous spO2 monitoring during a 6 minute walk. Although, the reproducibility of a 6 minute walk has been addressed in terms of a hospital test, simulated home test and actual home test (Guyatt), its inter-variability is not well studied. We propose to investigate the reliability and inter-variability of the 6 minute walk for oxygen prescription. Currently, two programs are providing pulmonary rehabilitation for COPD patients in the community. Patients perform 6 minute walks under supervision and are monitored by pulse oximetry on a routine basis as part of these programs. We plan to capture the oximetry data in order to determine the reliability of oxygen prescriptions using the 6 minute walk. Patients who are performing a 6 minute walk will be eligible for enrollment. Protocols for the 6 minute walk are already in place and approved by their respective authority in both of the Pulmonary Rehabilitation Programs. These patients will have repeat 6 minute walks on separate in close proximity to determine the reliability of spO2 on any given day. Statistical analysis will be done by the kappa statistic for inter-test agreement in a 3 dimensional matrix. We ask to waive consent for this study as there is no change to the daily routine of the 6 minute walks already being done as part of Pulmonary Rehabilitation. We plan only to capture the data from these walks.

Interventions

None listed

Sponsors

Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Taking part in Pulmonary Rehabilitation

Exclusion criteria

* Inability to perform 6MWT

Design outcomes

Primary

MeasureTime frameDescription
Kappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)All three 6MWTs should take place within 30 daysThe kappa statistic is a measure of the quality of a test. It is a ratio.

Countries

United States

Participant flow

Participants by arm

ArmCount
Single Arm Prospective Observational Study
Each subject will be their own control. Each subject will perform three 6MWTs. Intra-subject reproducibility is being tested. These will all be subjects in Pulmonary Rehab.
97
Total97

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyscreen failures (non-COPD patients)9

Baseline characteristics

CharacteristicSingle Arm Prospective Observational Study
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
52 Participants
Age, Categorical
Between 18 and 65 years
45 Participants
Age, Continuous70 years
STANDARD_DEVIATION 11
Region of Enrollment
United States
97 participants
Sex: Female, Male
Female
60 Participants
Sex: Female, Male
Male
37 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 88
serious
Total, serious adverse events
0 / 88

Outcome results

Primary

Kappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)

The kappa statistic is a measure of the quality of a test. It is a ratio.

Time frame: All three 6MWTs should take place within 30 days

ArmMeasureValue (NUMBER)
Single Arm Prospective Observational StudyKappa Statistic for Correlation of the Oxygen Saturation Across 3 Serial 6 Minute Walk Tests (6MWT)0.62 Ratio

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026